Abstract
Paravalvular leak incidence after mitral surgical replacement ranges from 7% to 17%. Between 1% and 5% of these are clinically significant. Large PVLs can cause important clinical manifestations such as heart failure or haemolysis. Current guidelines consider that surgical reparation is the gold-standard therapy in symptomatic patients with paravalvular leak. However, these recommendations are based in non-randomized observational registries. On the other hand, transcatheter paravalvular leak closure has shown excellent results with a low rate of complications, and nowadays it is considered the first option in selected patients in some experienced centres. In this review, we summarize the clinical manifestations, diagnosis, procedural details, and results of transcatheter mitral PVL closure.
Reference30 articles.
1. Update in Paravalvular Leak Closure
2. Transcatheter closure of paravalvular leaks: state of the art
3. Paravalvular Leaks—From Diagnosis to Management
4. 2021 ESC/EACTS Guidelines for the management of valvular heart disease;Vahanian;Eur. Heart J.,2021
5. 2020 ACC/AHA Guideline for the Management of Patients with Valvular Heart Disease;Otto;Circulation,2021
Cited by
5 articles.
订阅此论文施引文献
订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献